Holen Sie sich die Stockscreener-App
4.82
0.00%
0.00
Schlusskurs vom Vortag:
$4.82
Offen:
$4.77
24-Stunden-Volumen:
574.48K
Relative Volume:
0.64
Marktkapitalisierung:
$703.49M
Einnahmen:
$342.81M
Nettoeinkommen (Verlust:
$97.67M
KGV:
7.8438
EPS:
0.6145
Netto-Cashflow:
$50.46M
1W Leistung:
-2.43%
1M Leistung:
-4.17%
6M Leistung:
-32.49%
1J Leistung:
-40.38%
1-Tages-Spanne:
$4.71
$4.87
1-Wochen-Bereich:
$4.70
$4.99
52-Wochen-Spanne:
$4.70
$8.20
Mimedx Group Inc Stock (MDXG) Company Profile
Firmenname
Mimedx Group Inc
Sektor
Branche
Telefon
(770) 651-9100
Adresse
1775 W OAK COMMONS COURT, NE, MARIETTA
Compare MDXG vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.1602 | 2.87B | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
7.23 | 465.95M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.18 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
3.1578 | 350.59M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DWLD
Davis Select Worldwide ETF
|
45.21 | 0 | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-03-07 | Eingeleitet | Lake Street | Buy |
| 2023-10-27 | Eingeleitet | Craig Hallum | Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-07-26 | Eingeleitet | Northland Capital | Outperform |
| 2021-03-19 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Mimedx Group Inc Aktie (MDXG) Neueste Nachrichten
MiMedx (MDXG) Launches New AMNIOFIX Thyroid Shields - GuruFocus
Thyroid surgery shield shows 76% drop in vocal nerve damage in study - Stock Titan
MiMedx Group (NASDAQ:MDXG) Sets New 1-Year LowWhat's Next? - MarketBeat
The Rosen Law Firm Files Securities Fraud Class Action Against MiMedx Group, Inc.MDXG - AOL.com
MiMedx Group, Inc (MDXG) Stock Analysis: A Biotech Powerhouse with Nearly 100% Upside Potential - DirectorsTalk Interviews
InvestingPro Fair Value flagged MiMedx as overvalued before 47% drop By Investing.com - Investing.com Canada
Global Placenta Extract Market Size, Growth, Trends & Forecast to 2033 telaGen, BIOON, MiMedx Group - openPR.com
MiMedx Group (MDXG) Delivers Record Full Year Revenue - Finviz
MiMedx Group (NASDAQ:MDXG) Downgraded by Wall Street Zen to Buy - MarketBeat
Q2 EPS Estimates for MiMedx Group Lowered by Analyst - MarketBeat
MiMedx Group (NASDAQ:MDXG) Reaches New 1-Year LowWhat's Next? - MarketBeat
MiMedx Group (NASDAQ:MDXG) Stock Price Down 8.8%Here's What Happened - MarketBeat
MiMedx Group (MDXG) Revenue Jump To US$118.1 Million Tests Slow Growth Narrative - Sahm
MiMedx Group Q4 Earnings Call Highlights - Yahoo Finance
Transcript : MiMedx Group, Inc., Q4 2025 Earnings Call, Feb 25, 2026 - marketscreener.com
Earnings call transcript: MiMedx Q4 2025 sees robust growth, EPS beats forecast - Investing.com UK
MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results - The Globe and Mail
MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates - Nasdaq
MiMedx Group (NASDAQ:MDXG) Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
MIMEDX Group Inc (NASDAQ:MDXG) Stock Dips Despite Strong Earnings Beat - ChartMill
MiMedx (MDXG) Q4 2025 Earnings Call Transcript - AOL.com
MiMedx: Q4 Earnings Snapshot - marketscreener.com
Earnings Flash (MDXG) MiMedx Group, Inc. Posts Q4 Adjusted EPS $0.14 per Share, vs. FactSet Est of $0.09 - marketscreener.com
Earnings Flash (MDXG) MiMedx Group, Inc. Reports Q4 Revenue $118.1M, vs. FactSet Est of $106.8M - marketscreener.com
MiMedx (MDXG) details wound-care expansion, new products and Medicare shifts - Stock Titan
MiMedx Group, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
MiMedx Group, Inc. announces an Equity Buyback for $100 million worth of its shares. - marketscreener.com
What to Expect from MiMedx Group's Earnings - Benzinga
MiMedx Group Inc (MDXG) Q4 2025 Earnings Report Preview: What to Look For - GuruFocus
MiMedx Group, Inc (MDXG) Stock Analysis: Exploring an 81% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
MiMedx Group (MDXG): Citizens Initiates Coverage with Market Out - GuruFocus
MiMedx Group (NASDAQ:MDXG) Now Covered by Citizens Jmp - MarketBeat
MiMedx Group, Inc (NASDAQ:MDXG) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Beyond The Numbers: 4 Analysts Discuss MiMedx Group Stock - Benzinga
This MiMedx Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Citizens Initiates Coverage of MiMedx Group (MDXG) with Market Outperform Recommendation - Nasdaq
Citizens initiates MiMedx stock with outperform on reimbursement outlook By Investing.com - Investing.com Canada
Citizens initiates MiMedx stock with outperform on reimbursement outlook - Investing.com
How The MiMedx (MDXG) Investment Story Is Resetting Around CMS And Analyst Revisions - Yahoo Finance
MiMedx Group, Inc. authorizes a Buyback Plan. - marketscreener.com
What catalysts could drive MiMedx Group Inc. stock higherJuly 2025 Market Mood & Breakout Confirmation Trade Signals - mfd.ru
MSN Money - MSN
Will MiMedx Group Inc. stock benefit from AI adoption2025 Dividend Review & AI Forecasted Entry and Exit Points - mfd.ru
Stem Cell and Regenerative Therapy Markets, 2022-2025 & - GlobeNewswire
Stem Cell and Regenerative Therapy Markets, 2022-2025 & Forecast to 2030 Featuring Profiles of Leading CompaniesGilead Sciences, Novartis, Bristol-Myers Squibb, Organogenesis, MiMedx Group and More - Yahoo Finance
Aug Swings: What’s the MACD signal for MiMedx Group Inc.Weekly Profit Summary & Safe Capital Growth Plans - mfd.ru
Is MiMedx Group Inc. stock a good pick for beginnersBuy Signal & Daily Stock Trend Reports - mfd.ru
MiMedx (NASDAQ: MDXG) COO reports 61,961-share tax withholding on vesting - Stock Titan
MiMedx Group (MDXG) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Cantor Fitzgerald Issues Pessimistic Forecast for MiMedx Group (NASDAQ:MDXG) Stock Price - MarketBeat
MiMedx Group, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - Quiver Quantitative
Finanzdaten der Mimedx Group Inc-Aktie (MDXG)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.07%
0.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):